|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008838,
umls-concept:C0020823,
umls-concept:C0034656,
umls-concept:C0034897,
umls-concept:C0144576,
umls-concept:C0282460,
umls-concept:C0302592,
umls-concept:C0679729,
umls-concept:C1384494,
umls-concept:C1518578,
umls-concept:C2603343
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2009-8-5
|
|
pubmed:abstractText |
We undertook a randomized phase II trial to test whether the addition of paclitaxel (Taxol) to the cisplatin and ifosfamide (IP) combination could improve objective response (OR) rate, progression-free survival (PFS) and overall survival (OS) in patients with recurrent or metastatic cancer of the uterine cervix.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1569-8041
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1362-8
|
|
pubmed:meshHeading |
pubmed-meshheading:19457937-Adult,
pubmed-meshheading:19457937-Aged,
pubmed-meshheading:19457937-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19457937-Cisplatin,
pubmed-meshheading:19457937-Drug Administration Schedule,
pubmed-meshheading:19457937-Female,
pubmed-meshheading:19457937-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:19457937-Humans,
pubmed-meshheading:19457937-Ifosfamide,
pubmed-meshheading:19457937-Mesna,
pubmed-meshheading:19457937-Middle Aged,
pubmed-meshheading:19457937-Neoplasm Metastasis,
pubmed-meshheading:19457937-Paclitaxel,
pubmed-meshheading:19457937-Uterine Cervical Neoplasms
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Cooperative Oncology Group (HeCOG) study.
|
|
pubmed:affiliation |
Department of Clinical Therapeutics, Alexandra Hospital, University of Athens School of Medicine, Athens, Greece.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study,
Clinical Trial, Phase II
|
